BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9121801)

  • 1. Do aminoglycoside otic preparations cause ototoxicity in the presence of tympanic membrane perforations?
    Wong DL; Rutka JA
    Otolaryngol Head Neck Surg; 1997 Mar; 116(3):404-10. PubMed ID: 9121801
    [No Abstract]   [Full Text] [Related]  

  • 2. Ototoxicity of topical gentamicin preparations.
    Bath AP; Walsh RM; Bance ML; Rutka JA
    Laryngoscope; 1999 Jul; 109(7 Pt 1):1088-93. PubMed ID: 10401847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ototoxicity of ear drops: a clinical perspective.
    Linder TE; Zwicky S; Brändle P
    Am J Otol; 1995 Sep; 16(5):653-7. PubMed ID: 8588672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ototoxicity and topical eardrops.
    Marais J; Rutka JA
    Clin Otolaryngol Allied Sci; 1998 Aug; 23(4):360-7. PubMed ID: 9762501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ototoxicity of topical agents.
    Rohn GN; Meyerhoff WL; Wright CG
    Otolaryngol Clin North Am; 1993 Oct; 26(5):747-58. PubMed ID: 8233487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Topical ototoxicity: review over a 6-year period].
    Abelló P; Viñas JB; Vega J
    Acta Otorrinolaringol Esp; 1998; 49(5):353-6. PubMed ID: 9717322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gentamicin ear drops and ototoxicity: update.
    Stockwell M
    CMAJ; 2001 Jan; 164(1):93-4, 97-8. PubMed ID: 11202681
    [No Abstract]   [Full Text] [Related]  

  • 8. Aminoglycoside ear drop ototoxicity: a topical dilemma?
    Walby P; Stewart R; Kerr AG
    Clin Otolaryngol Allied Sci; 1998 Aug; 23(4):289-90. PubMed ID: 9762488
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk factors for bacterial infection to cause sensorineural hearing loss in eosinophilic otitis media.
    Masuda M; Esu Y; Iino Y; Yoshida N
    Auris Nasus Larynx; 2021 Apr; 48(2):207-213. PubMed ID: 32883575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors for sensorineural hearing loss in patients with tubotympanic otitis, cholesteatoma, and tympanic membrane retractions.
    Jesic SD; Jotic AD; Babic BB
    Otol Neurotol; 2012 Aug; 33(6):934-40. PubMed ID: 22722145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ototoxicity from ototopical aminoglycosides.
    Hui Y; Park A; Crysdale WS; Forte V
    J Otolaryngol; 1997 Feb; 26(1):53-6. PubMed ID: 9055175
    [No Abstract]   [Full Text] [Related]  

  • 12. Avoidance of chloramphenicol drops in the presence of a tympanic membrane perforation.
    Mendis D; Grainger J
    Clin Otolaryngol; 2011 Oct; 36(5):520-1. PubMed ID: 22032460
    [No Abstract]   [Full Text] [Related]  

  • 13. Topical aminoglycosides in the management of active mucosal chronic suppurative otitis media.
    Lancaster JL; Makura ZG; Porter G; McCormick M
    J Laryngol Otol; 1999 Jan; 113(1):10-2. PubMed ID: 10341911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auditory and Histopathological Effects of Topical Mercurochrome Treatment in Rats with Tympanic Membrane Perforation.
    Korkmaz S; Ceylan ME; Ceylan G; Dalgıç A; İnan S; Olgun L; Özüer MZ
    J Int Adv Otol; 2019 Apr; 15(1):22-27. PubMed ID: 30541727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intratympanic gentamicin in patients with Ménière's disease: analysis of our protocol].
    Martín Sanz E; Pérez Fernández N
    Acta Otorrinolaringol Esp; 2004; 55(6):270-6. PubMed ID: 15491114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological findings in clinical gentamicin ototoxicity.
    Keene M; Hawke M; Barber HO; Farkashidy J
    Arch Otolaryngol; 1982 Feb; 108(2):65-70. PubMed ID: 6977353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unilateral vestibulotoxicity due to systemic gentamicin therapy.
    Waterston JA; Halmagyi GM
    Acta Otolaryngol; 1998 Jul; 118(4):474-8. PubMed ID: 9726669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Labyrinthine involvement and multiple perforations of the tympanic membrane in acute otitis media due to group A streptococci.
    Kanazawa T; Hagiwara H; Kitamura K
    J Laryngol Otol; 2000 Jan; 114(1):47-9. PubMed ID: 10789411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vestibular toxic effects induced by once-daily aminoglycoside therapy.
    Dhanireddy S; Liles WC; Gates GA
    Arch Otolaryngol Head Neck Surg; 2005 Jan; 131(1):46-8. PubMed ID: 15655184
    [No Abstract]   [Full Text] [Related]  

  • 20. A screening program to detect aminoglycoside- induced ototoxicity.
    Teimoori M; Mistry G; Corallo C; Cheng AC
    Med J Aust; 2012 Aug; 197(4):216-7. PubMed ID: 22900867
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.